Nurix Therapeutics
Price & Volume
Stats
See more52W Range | $8.18-$22.49 |
Market Cap | $1.9B |
Shares Short | 13M |
Financials
See moreRevenue (12 Mos) | $83.6M |
Revenue Growth (YoY) | -37.3% |
Gross Profit (12 Mos) | -$217.4M |
Diluted EPS | -$2.97 |
News
See moreYahoo Finance • 6 days ago
Precision's Payoff: Targeted Therapies Drive $131B Solid Tumor Market Surge
Yahoo Finance • 9 days ago
Wells Fargo Reaffirms a Buy Rating on Nurix Therapeutics (NRIX), Sets a $30 PT
Yahoo Finance • 15 days ago
Cathie Wood tilts toward Robinhood, Bitcoin ETFs, trims Tesla, Iridium
Yahoo Finance • 22 days ago
Kymera Rockets, Pulling Nurix Higher. Does It Have The Next Dupixent?
About
CEO | Dr. Arthur T. Sands M.D., Ph.D. |
Address | 1700 Owens Street, San Francisco, CA, United States, 94158 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 286 |
